Yamada, T., Nakashima, Y., Kashiwada, T., Sonoda, H., Hattori, M., Kawanaka, H., Tsuji, Y., Makiyama, A., Kusumoto, T., Takahashi, I., Shinohara, Y., Goto, M., Shindo, Y., Sawada, K., Sakai, T., Shimokawa, M., Saeki, H., Oki, E. (2025). A multicenter randomized phase II study of trastuzumab biosimilar (CT-P6) and chemotherapy (SOX or CapeOX) in HER2-positive advanced/recurrent gastric cancer (KSCC: TROX study).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4029